China regulator fines two pharma firms 320 million yuan for monopolistic behaviour
On May 28, China's market regulator said it had fined two pharmaceutical companies 320 million yuan for entering into a monopolistic deal and abusing dominant market position. The State Administration of Market Regulation fined Grand Pharmaceutical 136 million yuan